Senestech (NASDAQ:SNES – Get Free Report) is one of 296 public companies in the “Chemicals” industry, but how does it contrast to its competitors? We will compare Senestech to related companies based on the strength of its profitability, institutional ownership, dividends, analyst recommendations, valuation, earnings and risk.
Profitability
This table compares Senestech and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Senestech | -275.26% | -98.70% | -66.45% |
| Senestech Competitors | -53.86% | -0.38% | -1.30% |
Analyst Recommendations
This is a summary of current ratings and price targets for Senestech and its competitors, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Senestech | 1 | 0 | 0 | 0 | 1.00 |
| Senestech Competitors | 3285 | 12263 | 14173 | 521 | 2.39 |
As a group, “Chemicals” companies have a potential upside of 12.13%. Given Senestech’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Senestech has less favorable growth aspects than its competitors.
Risk & Volatility
Senestech has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Comparatively, Senestech’s competitors have a beta of 0.94, meaning that their average stock price is 6% less volatile than the S&P 500.
Insider and Institutional Ownership
5.2% of Senestech shares are owned by institutional investors. Comparatively, 47.4% of shares of all “Chemicals” companies are owned by institutional investors. 2.2% of Senestech shares are owned by company insiders. Comparatively, 13.7% of shares of all “Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares Senestech and its competitors gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Senestech | $2.22 million | -$6.38 million | -0.48 |
| Senestech Competitors | $8.32 billion | $229.49 million | 6.16 |
Senestech’s competitors have higher revenue and earnings than Senestech. Senestech is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Summary
Senestech competitors beat Senestech on 13 of the 13 factors compared.
Senestech Company Profile
SenesTech, Inc. develops fertility-control products intended to help manage rodent populations. Its approach is designed to reduce reproduction rather than rely solely on conventional methods that remove rodents after they have become established. The company’s products include ContraPest, a liquid bait formulated to reduce fertility in rats, and Evolve, a soft-bait product for rodent population management. These products are intended for use in pest-control programs by professional customers and other organizations.
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
